![Interaction Between Spironolactone and Natriuretic Peptides in Patients With Heart Failure and Preserved Ejection Fraction: From the TOPCAT Trial - ScienceDirect Interaction Between Spironolactone and Natriuretic Peptides in Patients With Heart Failure and Preserved Ejection Fraction: From the TOPCAT Trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2213177917300434-gr1.jpg)
Interaction Between Spironolactone and Natriuretic Peptides in Patients With Heart Failure and Preserved Ejection Fraction: From the TOPCAT Trial - ScienceDirect
![The use of diuretics in heart failure with congestion — a position statement from the Heart Failure Association of the European Society of Cardiology - Mullens - 2019 - European Journal of The use of diuretics in heart failure with congestion — a position statement from the Heart Failure Association of the European Society of Cardiology - Mullens - 2019 - European Journal of](https://onlinelibrary.wiley.com/cms/asset/25d3e21b-41df-4ae1-8be7-fe4bfa7275bb/ejhf1369-fig-0002-m.jpg)
The use of diuretics in heart failure with congestion — a position statement from the Heart Failure Association of the European Society of Cardiology - Mullens - 2019 - European Journal of
![Association Between Mineralocorticoid Receptor Antagonist Use and Outcome in Myocardial Infarction Patients With Heart Failure | Journal of the American Heart Association Association Between Mineralocorticoid Receptor Antagonist Use and Outcome in Myocardial Infarction Patients With Heart Failure | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/278a305a-3e22-4f29-9f4c-2bd849029d67/jah33310-fig-0001.png)
Association Between Mineralocorticoid Receptor Antagonist Use and Outcome in Myocardial Infarction Patients With Heart Failure | Journal of the American Heart Association
![Mineralocorticoid receptor antagonists, a class beyond spironolactone — Focus on the special pharmacologic properties of eplerenone - International Journal of Cardiology Mineralocorticoid receptor antagonists, a class beyond spironolactone — Focus on the special pharmacologic properties of eplerenone - International Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/40a968ae-01ee-41d2-aa8a-0774c0b375e8/gr1.jpg)
Mineralocorticoid receptor antagonists, a class beyond spironolactone — Focus on the special pharmacologic properties of eplerenone - International Journal of Cardiology
![Diuretics the role of different portions of the nephron in ion exchange; the sites of action and pharmacology of diuretics; the therapeutic applications. - ppt video online download Diuretics the role of different portions of the nephron in ion exchange; the sites of action and pharmacology of diuretics; the therapeutic applications. - ppt video online download](https://slideplayer.com/slide/7598890/25/images/33/Spironolactone+Mechanism+of+Action.jpg)
Diuretics the role of different portions of the nephron in ion exchange; the sites of action and pharmacology of diuretics; the therapeutic applications. - ppt video online download
![Reappraisal on pharmacological and mechanical treatments of heart failure | Cardiovascular Diabetology | Full Text Reappraisal on pharmacological and mechanical treatments of heart failure | Cardiovascular Diabetology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12933-020-01024-5/MediaObjects/12933_2020_1024_Fig2_HTML.png)
Reappraisal on pharmacological and mechanical treatments of heart failure | Cardiovascular Diabetology | Full Text
![Effects of mineralocorticoid receptor antagonist spironolactone on atrial conduction and remodeling in patients with heart failure - Journal of Cardiology Effects of mineralocorticoid receptor antagonist spironolactone on atrial conduction and remodeling in patients with heart failure - Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/163318/1044122/gr1.jpg)
Effects of mineralocorticoid receptor antagonist spironolactone on atrial conduction and remodeling in patients with heart failure - Journal of Cardiology
![Myocardial Effects of Aldosterone Antagonism in Heart Failure With Preserved Ejection Fraction | Journal of the American Heart Association Myocardial Effects of Aldosterone Antagonism in Heart Failure With Preserved Ejection Fraction | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/55470a3e-323c-4eeb-84e3-793de6792c53/jah34641-fig-0001.png)
Myocardial Effects of Aldosterone Antagonism in Heart Failure With Preserved Ejection Fraction | Journal of the American Heart Association
![Potassium Sparing Diuretics - Pharmacological Actions, Pharmacokinetics, Uses, Adverse Effects, Interactions | Pharmacology Potassium Sparing Diuretics - Pharmacological Actions, Pharmacokinetics, Uses, Adverse Effects, Interactions | Pharmacology](http://www.pharmacy180.com/media/imgph02/Xhz6NMl.jpg)